Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Obes Sci Pract ; 4(4): 338-346, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-30151228

RESUMO

OBJECTIVE: Patient-provider communication has been found to be less patient centred, on average, with patients who are members of stigmatized or minority groups. Obesity is a stigmatized condition, and thus, people with obesity may experience less patient-centred communication (PCC). The objective of this study was to assess the association between patient body mass index (BMI) and self-reported quality of PCC experienced over a 12-month period and whether that relationship differed for men and women. METHODS: Data collected for the National Cancer Institute's Health Information National Trends Survey were analysed. Respondents who reported a BMI ≥ 18.5 kg/m2 and indicated having seen a healthcare provider outside of an emergency room in the last 12 months were included. PCC was measured using a validated six-item scale. Multivariate logistic regression was used to model the odds of reporting PCC greater than the sample median. RESULTS: Compared with people with normal weight BMIs, no associations were found between overweight (odds ratio [OR] = 0.84, p = 0.17), class I & II obesity (OR = 0.94, p = 0.68) or class III obesity (OR = 0.86, p = 0.47) and PCC. There was a significant interaction (p = 0.015) such that for men, but not women, higher BMI was associated with less PCC. CONCLUSION: Unlike evidence that women experience more weight stigma, in the healthcare domain, men may be at elevated risk of experiencing communication influenced by weight stigma.

2.
Eur J Clin Nutr ; 66(5): 639-44, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22252109

RESUMO

OBJECTIVES: Parenteral nutrition (PN) is critical in neonatal and pediatric care for patients unable to tolerate enteral feeding. This study assessed the total costs of compounding PN therapy for neonates, infants and children. METHODS: Face-to-face and telephone interviews were conducted in 12 hospitals across four European countries (Belgium, France, Germany and UK) to collect information on resources utilized to compound PN, including nutrients, staff time, equipment cost and supplies. A bottom-up cost model was constructed to assess total costs of PN therapy by assigning monetary values to the resource utilization using published list prices and interview data. RESULTS: A total of 49,922 PN bags per year were used to treat 4295 neonatal and pediatric patients among these hospitals. The daily total costs of one compounded PN bag for neonates in the 12 hospitals across the four countries equalled euro 55.16 (Belgium euro 53.26, France euro 46.23, Germany euro 64.05, UK L 37.43/\[euro]42.86). Overall, nutrients accounted for 25% of total costs, supplies 18%, wages 54% and equipment 3%. Average costs per bag for infants <2 year were euro 84.52 (euro 74.65 in Belgium, euro 83.84 in France, euro 92.70 in Germany and L 52.63/euro 60.26 in the UK), and for children 2-18 years euro 118.02 (euro 93.85 in Belgium, euro 121.35 in France, euro 124.54 in Germany and L 69.49/euro 79.56 in the UK), of which 63% is attributable to nutrients and 28% to wages. CONCLUSION: The data indicated that PN costs differ among countries and a major proportion was due to staff time (L 1=euro 1.144959).


Assuntos
Custos de Cuidados de Saúde , Recursos em Saúde/economia , Soluções de Nutrição Parenteral/economia , Nutrição Parenteral/economia , Fatores Etários , Criança , Pré-Escolar , Comércio , Custos e Análise de Custo , Europa (Continente) , Humanos , Lactente , Recém-Nascido , Entrevistas como Assunto , Pediatria/economia
3.
Gene ; 168(2): 271-2, 1996 Feb 12.
Artigo em Inglês | MEDLINE | ID: mdl-8654958

RESUMO

We isolated and sequenced a 2026-bp murine Nkx-2.2 cDNA clone that contains an open reading frame encoding 273 amino acids (aa). The 273-aa protein includes a homeobox, an NK-2 box and a N-terminal decapeptide found in other Nk family members.


Assuntos
Genes Homeobox , Proteínas de Homeodomínio/genética , Camundongos/genética , Fatores de Transcrição/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , DNA Complementar , Proteína Homeobox Nkx-2.2 , Dados de Sequência Molecular , Família Multigênica , Fases de Leitura Aberta , Telencéfalo/metabolismo , Transcrição Gênica , Proteínas de Peixe-Zebra
4.
Development ; 121(12): 3923-33, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8575293

RESUMO

Over the last century, several morphological models of forebrain organization have been proposed that hypothesize alternative topological solutions for the relationships of the histogenic primordia. Central to all of these models are their definitions of the longitudinal axis and the longitudinal organization of the neural plate and neural tube. To understand the longitudinal organization of the anterior brain, we have sought to identify molecular properties that are continuous along the entire longitudinal axis of the embryonic CNS. In this essay, we describe studies of the expression of several genes in the mouse between 7.5 (presomite stage) and 10.5 days post coitum (dpc) that provide evidence for the trajectory of the anterior-posterior axis and the longitudinal organization of the anterior CNS. Specifically, we report that the expression of noggin, sonic hedgehog and Nkx-2.2 define longitudinal columns of cells that are present along the entire CNS axis. Within the forebrain, the expression of these genes, as well as that of Nkx-2.1 and BF-1, are in distinct longitudinal regions in the neural plate and tube. We demonstrate that the earliest longitudinal axon pathways of the forebrain are spatially correlated with the longitudinal domain defined by Nkx-2.2. Finally, expression of the former genes, and Otx-1 and Emx-2, suggests that the cephalic neural plate is organized into molecularly distinct domains delimited by longitudinal and transverse borders; these results provide a foundation for defining the mechanisms that pattern the neural plate.


Assuntos
Genes Homeobox , Prosencéfalo/embriologia , Animais , Sistema Nervoso Central/embriologia , Expressão Gênica , Camundongos , Morfogênese/genética
5.
Cereb Cortex ; 5(1): 64-78, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7719131

RESUMO

Stem cells isolated from the ventricular zone of embryonic day 12.5 rat telencephalon progressively proliferate and differentiate in vitro into three major classes of amino acid-containing neurons, glutamate, aspartate, and GABA. We quantitatively examined the effect of basic fibroblast growth factor (bFGF) and nerve growth factor (NGF) on amino acid-containing neurons. bFGF caused a threefold increase in glutamate-containing neurons, while the number of GABA- and aspartate-containing neurons was not significantly changed. In contrast, NGF did not alter the number of amino acid-containing neurons. The ratio of glutamate- to GABA-containing neurons in untreated or NGF-treated cultures was 0.6:1. In the bFGF-treated cultures, this ratio was 1.4:1, which closely approximates the ratio in the cerebral cortex in vivo. Treatment with antisense oligonucleotides targeted to bFGF mRNA provoked a 50% decrease in the number of glutamate-containing neurons but had no significant effect on the GABA-containing neurons. Thus, diffusible factors such as bFGF may play an important role in determining the relative proportion of excitatory versus inhibitory neurons in the cerebral cortex by selectively regulating the proliferation of stem cells committed to different neurotransmitter phenotypes.


Assuntos
Química Encefálica/efeitos dos fármacos , Córtex Cerebral/crescimento & desenvolvimento , Fator 2 de Crescimento de Fibroblastos/farmacologia , Ácido Glutâmico/metabolismo , Neurônios/efeitos dos fármacos , Animais , Bromodesoxiuridina , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Córtex Cerebral/citologia , Processamento de Imagem Assistida por Computador , Imuno-Histoquímica , Fatores de Crescimento Neural/farmacologia , Neuroglia/efeitos dos fármacos , Neurônios/metabolismo , Neurotransmissores/metabolismo , Oligonucleotídeos Antissenso , Fenótipo , Ratos
6.
Biochem Pharmacol ; 47(11): 1981-8, 1994 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-7516657

RESUMO

(6R)5,10-Dideazatetrahydrofolic acid (DDATHF, Lometrexol), a potent antitumor drug in vivo and in vitro, is an inhibitor of the two folate-dependent enzymes in the de novo purine biosynthesis pathway: glycinamide ribonucleotide (GAR) and amino imidazole carboxamide (AICAR) transformylases. A single dose of DDATHF (50 mg/kg, i.p.) in C57/BL6 mice caused a prolonged depletion of purine nucleotides (ATP and GTP) in colon 38 tumor and only a temporary effect in liver. GAR transformylase activity was higher in colon 38 tumor than in liver, but a kinetic analysis on the purified enzyme showed no differences in Ki values for DDATHF or Km values for the folate substrate. As a consequence of de novo purine synthesis inhibition, there was a 2- to 3-fold elevation of 5-phosphoribosyl-1-pyrophosphate pools in colon 38 tumor between 4 and 12 hr after DDATHF administration. When DDATHF (50 mg/kg) was administered 4 or 8 hr prior to 5-fluorouracil (5-FU; 85 mg/kg, i.p., weekly), these biochemical effects significantly increased the antitumor activity of 5-FU, with a modest increase in toxicity. Lower doses of DDATHF (25 and 37.5 mg/kg) when combined with 5-FU also resulted in an improved antitumor activity without additional toxicity. The two different schedules of administration for DDATHF, 4 and 8 hr prior to 5-FU, showed no differences in antitumor activity or toxicity.


Assuntos
Antineoplásicos/farmacologia , Neoplasias do Colo/tratamento farmacológico , Fluoruracila/uso terapêutico , Hidroximetil e Formil Transferases , Tetra-Hidrofolatos/farmacologia , Aciltransferases/análise , Animais , Sinergismo Farmacológico , Feminino , Camundongos , Camundongos Endogâmicos C57BL , Fosforribosil Pirofosfato/metabolismo , Fosforribosilglicinamido Formiltransferase , Nucleotídeos de Purina/biossíntese , Tetra-Hidrofolatos/farmacocinética
7.
Brain Res Mol Brain Res ; 19(1-2): 76-82, 1993 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8103187

RESUMO

In this paper, we tested whether physiological activators of the cAMP second messenger pathway in primary cultures of neurons from rat cerebral cortex directly induce c-fos and other immediate early gene (IEG) transcription factors. We have found that brief (30 s to 2 min) stimulation of neurons with vasoactive intestinal peptide (VIP) and SKF-38393, a D1-dopaminergic receptor agonist, potently increased mRNA levels for the IEGs c-fos, jun-B, and NGFI-A, with weaker increases for c-jun. This action was mimicked by forskolin and dibutyryl cAMP. IEG induction by VIP and dibutyryl cAMP was not blocked by excitatory amino acid receptor antagonists or by blockers of dihydropyridine-sensitive calcium channels. Moreover, calcium-free medium did not modify IEG induction by dibutyryl cAMP, suggesting that cAMP can directly regulate IEG expression in differentiated neurons independently of calcium.


Assuntos
Bucladesina/farmacologia , Córtex Cerebral/metabolismo , Colforsina/farmacologia , AMP Cíclico/fisiologia , Regulação da Expressão Gênica/fisiologia , Proteínas Imediatamente Precoces , Neurônios/metabolismo , RNA Mensageiro/biossíntese , Fatores de Transcrição/biossíntese , 2,3,4,5-Tetra-Hidro-7,8-Di-Hidroxi-1-Fenil-1H-3-Benzazepina/farmacologia , Animais , Animais Recém-Nascidos , Células Cultivadas , Proteínas de Ligação a DNA/biossíntese , Dopaminérgicos/farmacologia , Proteína 1 de Resposta de Crescimento Precoce , Ergolinas/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Genes fos , Genes jun , Glutamatos/farmacologia , Ácido Glutâmico , Imuno-Histoquímica , Cinética , Neuroglia/metabolismo , Neurônios/efeitos dos fármacos , Quimpirol , Ratos , Sistemas do Segundo Mensageiro , Peptídeo Intestinal Vasoativo/farmacologia
10.
Scand J Infect Dis ; 13(4): 269-72, 1981.
Artigo em Inglês | MEDLINE | ID: mdl-7031860

RESUMO

Sera from 25 patients showing a 4-fold or greater rise in polyvalent IFA titer against Legionella pneumophila were examined for the presence of agglutinating antibodies and the titers of specific IgG and IgM immunoglobulins. Agglutinating antibodies were detected in 20 patients (80%) at titers paralleling and amounts of specific IgM present. In sera from the remaining 5 patients (20%), agglutinating antibodies and specific IgM were absent. In this study the class of antibody produced following infection with L. Pneumophila varied from patient to patient. Specific IgM or IgG only was produced or both classes of immunoglobulin appeared concurrently. IFA, using a polyvalent antihuman conjugate, detected both IgG and IgM but cross reactions among the L. pneumophila serogroups occurred in sera from 40.5% of the patients we examined. Tube agglutination measured mainly specific IgM and no cross reactions were evident with this technique. The value of a rapid tube agglutination test as an adjunct to IFA in the serodiagnosis of legionellosis was illustrated in this study.


Assuntos
Aglutininas/análise , Anticorpos Antibacterianos/análise , Imunoglobulina G/análise , Imunoglobulina M/análise , Legionella/imunologia , Especificidade de Anticorpos , Imunofluorescência , Humanos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...